These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38057180)

  • 61. Three-dimensional shear-wave elastography for differentiating benign and malignant breast lesions: comparison with two-dimensional shear-wave elastography.
    Youk JH; Gweon HM; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2013 Jun; 23(6):1519-27. PubMed ID: 23212276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of strain and shear wave elastography for the differentiation of benign from malignant breast lesions, combined with B-mode ultrasonography: qualitative and quantitative assessments.
    Youk JH; Son EJ; Gweon HM; Kim H; Park YJ; Kim JA
    Ultrasound Med Biol; 2014 Oct; 40(10):2336-44. PubMed ID: 25130444
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study.
    Fu Y; Lei YT; Huang YH; Mei F; Wang S; Yan K; Wang YH; Ma YH; Cui LG
    Eur Radiol; 2024 Nov; 34(11):7080-7089. PubMed ID: 38724768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer.
    Wang J; Tian C; Zheng BJ; Zhang J; Jiao DC; Qu JR; Liu ZZ
    BMC Cancer; 2024 May; 24(1):549. PubMed ID: 38693523
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Choi SJ; Park KJ; Heo C; Park BW; Kim M; Kim JK
    Clin Radiol; 2021 Aug; 76(8):627.e13-627.e21. PubMed ID: 33762138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Power Doppler Ultrasonography and Shear Wave Elastography as Complementary Imaging Methods for Suspected Local Breast Cancer Recurrence.
    Jales RM; Dória MT; Serra KP; Miranda MM; Menossi CA; Schumacher K; Sarian LO
    J Ultrasound Med; 2018 Jun; 37(6):1493-1501. PubMed ID: 29205428
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantification of elastic heterogeneity using contourlet-based texture analysis in shear-wave elastography for breast tumor classification.
    Zhang Q; Xiao Y; Chen S; Wang C; Zheng H
    Ultrasound Med Biol; 2015 Feb; 41(2):588-600. PubMed ID: 25444693
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A model combining BI-RADS® descriptors from pre-treatment B-mode breast ultrasound with clinicopathological tumor features shows promise in the prediction of residual disease after neoadjuvant chemotherapy.
    Kapetas P; Aggarwal R; Altuwayjiri B; Pinker K; Clauser P; Helbich TH; Baltzer PAT
    Eur J Radiol; 2024 Sep; 178():111649. PubMed ID: 39094464
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer.
    Zeng Q; Xiong F; Liu L; Zhong L; Cai F; Zeng X
    Acad Radiol; 2023 Sep; 30 Suppl 2():S38-S49. PubMed ID: 37169624
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiomics With Attribute Bagging for Breast Tumor Classification Using Multimodal Ultrasound Images.
    Li Y; Liu Y; Zhang M; Zhang G; Wang Z; Luo J
    J Ultrasound Med; 2020 Feb; 39(2):361-371. PubMed ID: 31432552
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic value of commercially available shear-wave elastography for breast cancers: integration into BI-RADS classification with subcategories of category 4.
    Youk JH; Gweon HM; Son EJ; Han KH; Kim JA
    Eur Radiol; 2013 Oct; 23(10):2695-704. PubMed ID: 23652850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of radiomics-based machine-learning classifiers for the pretreatment prediction of pathologic complete response to neoadjuvant therapy in breast cancer.
    Li X; Li C; Wang H; Jiang L; Chen M
    PeerJ; 2024; 12():e17683. PubMed ID: 39026540
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fusion Radiomics-Based Prediction of Response to Neoadjuvant Chemotherapy for Osteosarcoma.
    Zheng F; Yin P; Liang K; Wang Y; Hao W; Hao Q; Hong N
    Acad Radiol; 2024 Jun; 31(6):2444-2455. PubMed ID: 38151381
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions.
    Chang JM; Won JK; Lee KB; Park IA; Yi A; Moon WK
    AJR Am J Roentgenol; 2013 Aug; 201(2):W347-56. PubMed ID: 23883252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Accuracy of tumor size measurement: comparison of B-mode ultrasound, strain elastography, and 2D and 3D shear wave elastography with histopathological lesion size.
    Farrokh A; Maass N; Treu L; Heilmann T; Schäfer FK
    Acta Radiol; 2019 Apr; 60(4):451-458. PubMed ID: 30043622
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
    Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
    Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
    BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter.
    Piotrzkowska-Wróblewska H; Dobruch-Sobczak K; Klimonda Z; Karwat P; Roszkowska-Purska K; Gumowska M; Litniewski J
    PLoS One; 2019; 14(3):e0213749. PubMed ID: 30870478
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Construction and validation of a personalized nomogram of ultrasound for pretreatment prediction of breast cancer patients sensitive to neoadjuvant chemotherapy.
    Zhang MQ; Du Y; Zha HL; Liu XP; Cai MJ; Chen ZH; Chen R; Wang J; Wang SJ; Zhang JL; Li CY
    Br J Radiol; 2022 Dec; 95(1140):20220626. PubMed ID: 36378247
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.